BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 14500571)

  • 1. Estrogen inhibits paclitaxel-induced apoptosis via the phosphorylation of apoptosis signal-regulating kinase 1 in human ovarian cancer cell lines.
    Mabuchi S; Ohmichi M; Kimura A; Nishio Y; Arimoto-Ishida E; Yada-Hashimoto N; Tasaka K; Murata Y
    Endocrinology; 2004 Jan; 145(1):49-58. PubMed ID: 14500571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
    Hayakawa J; Ohmichi M; Kurachi H; Kanda Y; Hisamoto K; Nishio Y; Adachi K; Tasaka K; Kanzaki T; Murata Y
    Cancer Res; 2000 Nov; 60(21):5988-94. PubMed ID: 11085518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma membrane estrogen receptors signal to antiapoptosis in breast cancer.
    Razandi M; Pedram A; Levin ER
    Mol Endocrinol; 2000 Sep; 14(9):1434-47. PubMed ID: 10976921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1.
    Kim AH; Khursigara G; Sun X; Franke TF; Chao MV
    Mol Cell Biol; 2001 Feb; 21(3):893-901. PubMed ID: 11154276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both estrogen and raloxifene protect against beta-amyloid-induced neurotoxicity in estrogen receptor alpha-transfected PC12 cells by activation of telomerase activity via Akt cascade.
    Du B; Ohmichi M; Takahashi K; Kawagoe J; Ohshima C; Igarashi H; Mori-Abe A; Saitoh M; Ohta T; Ohishi A; Doshida M; Tezuka N; Takahashi T; Kurachi H
    J Endocrinol; 2004 Dec; 183(3):605-15. PubMed ID: 15590986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ASK1 resistant neuroblastoma is deficient in activation of p38 kinase.
    Arvidsson Y; Hamazaki TS; Ichijo H; Funa K
    Cell Death Differ; 2001 Oct; 8(10):1029-37. PubMed ID: 11598801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of FADD is critical for sensitivity to anticancer drug-induced apoptosis.
    Shimada K; Matsuyoshi S; Nakamura M; Ishida E; Kishi M; Konishi N
    Carcinogenesis; 2004 Jul; 25(7):1089-97. PubMed ID: 15001534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
    Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
    Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway.
    Yang YI; Lee KT; Park HJ; Kim TJ; Choi YS; Shih IeM; Choi JH
    Carcinogenesis; 2012 Dec; 33(12):2488-98. PubMed ID: 23027625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
    Mabuchi S; Ohmichi M; Nishio Y; Hayasaka T; Kimura A; Ohta T; Kawagoe J; Takahashi K; Yada-Hashimoto N; Seino-Noda H; Sakata M; Motoyama T; Kurachi H; Testa JR; Tasaka K; Murata Y
    Clin Cancer Res; 2004 Nov; 10(22):7645-54. PubMed ID: 15569997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel.
    Mabuchi S; Ohmichi M; Kimura A; Hisamoto K; Hayakawa J; Nishio Y; Adachi K; Takahashi K; Arimoto-Ishida E; Nakatsuji Y; Tasaka K; Murata Y
    J Biol Chem; 2002 Sep; 277(36):33490-500. PubMed ID: 12087097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-administration of perifosine with paclitaxel synergistically induces apoptosis in ovarian cancer cells: more than just AKT inhibition.
    Sun H; Yu T; Li J
    Cancer Lett; 2011 Nov; 310(1):118-28. PubMed ID: 21775054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen inhibits cell proliferation via mitogen-activated protein kinase cascades in human ovarian cancer cell lines in a manner not dependent on the expression of estrogen receptor or the sensitivity to cisplatin.
    Mabuchi S; Ohmichi M; Kimura A; Ikebuchi Y; Hisamoto K; Arimoto-Ishida E; Nishio Y; Takahashi K; Tasaka K; Murata Y
    Endocrinology; 2004 Mar; 145(3):1302-13. PubMed ID: 14645110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel induces inactivation of p70 S6 kinase and phosphorylation of Thr421 and Ser424 via multiple signaling pathways in mitosis.
    Le XF; Hittelman WN; Liu J; McWatters A; Li C; Mills GB; Bast RC
    Oncogene; 2003 Jan; 22(4):484-97. PubMed ID: 12555062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of paclitaxel-induced apoptosis by galectin-13 overexpression via activation of Ask-1-p38-MAP kinase and JNK/SAPK pathways and suppression of Akt and ERK1/2 activation in U-937 human macrophage cells.
    Boronkai A; Bellyei S; Szigeti A; Pozsgai E; Bognar Z; Sumegi B; Gallyas F
    Eur J Cell Biol; 2009 Dec; 88(12):753-63. PubMed ID: 19717209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells.
    Wang TH; Popp DM; Wang HS; Saitoh M; Mural JG; Henley DC; Ichijo H; Wimalasena J
    J Biol Chem; 1999 Mar; 274(12):8208-16. PubMed ID: 10075725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in SiHa human cervical cancer cells.
    Liu B; Fang M; Lu Y; Lu Y; Mills GB; Fan Z
    Br J Cancer; 2001 Jul; 85(2):303-11. PubMed ID: 11461094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small molecule compound inhibits AKT pathway in ovarian cancer cell lines.
    Tang HJ; Jin X; Wang S; Yang D; Cao Y; Chen J; Gossett DR; Lin J
    Gynecol Oncol; 2006 Feb; 100(2):308-17. PubMed ID: 16209885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laminar flow inhibits TNF-induced ASK1 activation by preventing dissociation of ASK1 from its inhibitor 14-3-3.
    Liu Y; Yin G; Surapisitchat J; Berk BC; Min W
    J Clin Invest; 2001 Apr; 107(7):917-23. PubMed ID: 11285311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akt involvement in paclitaxel chemoresistance of human ovarian cancer cells.
    Kim SH; Juhnn YS; Song YS
    Ann N Y Acad Sci; 2007 Jan; 1095():82-9. PubMed ID: 17404021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.